Trandate and Vytorin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Trandate (labetalol hydrochloride) and Vytorin (ezetimibe; simvastatin). Common drug interactions include neutropenia among females and flushing among males.
The phase IV clinical study analyzes what interactions people have when they take Trandate and Vytorin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Trandate?
Trandate has active ingredients of labetalol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 1,735 Trandate users. Check the latest studies of Trandate.
What is Vytorin?
Vytorin has active ingredients of ezetimibe; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 20,084 Vytorin users. Check the latest studies of Vytorin.
13 people who take Trandate and Vytorin together, and have interactions are studied.

What are the common drug interactions of Trandate and Vytorin, by gender? *:
female:
- Neutropenia (an abnormally low number of neutrophils)
- Cough
- Thrombocytopenia (decrease of platelets in blood)
- Anaemia (lack of blood)
- Haematotoxicity (toxins that destroy red blood cells)
- Spinal disorder (disease of spine a back bone)
- Vaginal infection
- Productive cough
- Chronic kidney disease
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
male:
- Flushing (the warm, red condition of human skin)
- Pruritus (severe itching of the skin)
- Hypersensitivity
- Lethargy (tiredness)
- Muscular weakness (muscle weakness)
- Nausea (feeling of having an urge to vomit)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Pulmonary congestion (congestion in the lungs)
- Renal failure (kidney dysfunction)
- Renal oncocytoma (a tumour of the kidney made up of oncocytes, a special kind of cell)
What are the common drug interactions of Trandate and Vytorin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Anxiety
- Blood glucose increased
- Cardiomegaly (increased size of heart than normal)
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Electrocardiogram qt prolonged
- Haemoglobin decreased
- Hypersensitivity
- Lethargy (tiredness)
- Muscular weakness (muscle weakness)
50-59:
- Neutropenia (an abnormally low number of neutrophils)
- Cough
- Thrombocytopenia (decrease of platelets in blood)
- Anaemia (lack of blood)
- Haematotoxicity (toxins that destroy red blood cells)
- Spinal disorder (disease of spine a back bone)
- Vaginal infection
- Productive cough
- Chronic kidney disease
- Renal failure (kidney dysfunction)
60+:
- Application site rash
- Blood pressure inadequately controlled
- Chronic kidney disease
- Fall
- Gait disturbance
- Nephrogenic anaemia (anaemia due to kidney disease)
- Oedema peripheral (superficial swelling)
- Renal failure (kidney dysfunction)
- Renal oncocytoma (a tumour of the kidney made up of oncocytes, a special kind of cell)
- Wrist fracture
What are the existing conditions these people have? *
- Wound Complication: 5 people, 38.46%
- Multiple Myeloma (cancer of the plasma cells): 5 people, 38.46%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 38.46%
- Upper Respiratory Tract Infection: 5 people, 38.46%
- Mouth Ulcers: 5 people, 38.46%
- Insomnia (sleeplessness): 5 people, 38.46%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 15.38%
- Sleep Disorder: 2 people, 15.38%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
- Pain: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Trandate and Vytorin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Trandate and Vytorin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Trandate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vytorin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Trandate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vytorin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on labetalol hydrochloride and ezetimibe; simvastatin (the active ingredients of Trandate and Vytorin, respectively), and Trandate and Vytorin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Arteriosclerosis Of The Extremities and Acute Kidney Failure - 8 seconds ago
- Drug interactions of Coreg and Nasacort - 23 seconds ago
- Could Phenazopyridine Hcl cause Dizziness? - 23 seconds ago
- Could Steglatro cause Fatigue? - 28 seconds ago
- Could Famotidine cause Vocal Cord Disorder? - 29 seconds ago
- Could Coreg cause Pulmonary Valve Incompetence? - 30 seconds ago
- Could Abraxane cause Canker Sores? - 36 seconds ago
- Drug interactions of Ciprofloxacin and Tigecycline - 37 seconds ago
- Could Polivy cause Lymphocyte Count Decreased? - 37 seconds ago
- Could Zejula cause Restless Leg Syndrome? - 46 seconds ago